ALTO-203 for Major Depressive Disorder and Anhedonia: Phase 2 Study Initiated

Retrieved on: 2024-04-03 15:26:45

Tags for this article:

Click the tags to see associated articles and topics

ALTO-203 for Major Depressive Disorder and Anhedonia: Phase 2 Study Initiated. View article details on hiswai:

Excerpt

Alto Neuroscience has initiated its phase 2 double-blind, single- and multiple-dose study to determine the potential of ALTO-203 as an ...

Article found on: www.psychiatrictimes.com